<div><div><table><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><div><span></span></div></td><td><span>Alphabet Inc.</span></td></tr></table></div></div><ix:continuation><div><span>Deferred Income Taxes</span></div><div><span>Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. <ix:nonnumeric>Significant components of our deferred tax assets and liabilities were as follows (in millions):</ix:nonnumeric></span></div><div><ix:continuation><table><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td><span>As of December 31,</span></td></tr><tr><td></td><td><span>2021</span></td><td></td><td><span>2022</span></td></tr><tr><td><span>Deferred tax assets:</span></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td><span>Accruals and reserves not currently deductible</span></td><td><span>$</span></td><td><span><ix:nonfraction>1,816</ix:nonfraction> </span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>1,956</ix:nonfraction> </span></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td><span>Tax credits</span></td><td><span><ix:nonfraction>5,179</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>6,002</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Net operating losses</span></td><td><span><ix:nonfraction>1,790</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>2,557</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Operating leases</span></td><td><span><ix:nonfraction>2,503</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>2,711</ix:nonfraction> </span></td><td></td></tr><tr><td><div><span>Capitalized research and development</span><span>(1)</span></div></td><td><span><ix:nonfraction>1,843</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>10,381</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Other</span></td><td><span><ix:nonfraction>1,665</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>3,244</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Total deferred tax assets</span></td><td><span><ix:nonfraction>14,796</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>26,851</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Valuation allowance</span></td><td><span>(<ix:nonfraction>7,129</ix:nonfraction>)</span></td><td></td><td></td><td><span>(<ix:nonfraction>9,553</ix:nonfraction>)</span></td><td></td></tr><tr><td><span>Total deferred tax assets net of valuation allowance</span></td><td><span><ix:nonfraction>7,667</ix:nonfraction> </span></td><td></td><td></td><td><span><ix:nonfraction>17,298</ix:nonfraction> </span></td><td></td></tr><tr><td><span>Deferred tax liabilities:</span></td><td></td><td></td><td></td></tr><tr><td><span>Property and equipment, net</span></td><td><span>(<ix:nonfraction>5,237</ix:nonfraction>)</span></td><td></td><td></td><td><span>(<ix:nonfraction>6,607</ix:nonfraction>)</span></td><td></td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td><span>Net investment gains</span></td><td><span>(<ix:nonfraction>3,229</ix:nonfraction>)</span></td><td></td><td></td><td><span>(<ix:nonfraction>2,361</ix:nonfraction>)</span></td><td></td></tr><tr><td><span>Operating leases</span></td><td><span>(<ix:nonfraction>2,228</ix:nonfraction>)</span></td><td></td><td></td><td><span>(<ix:nonfraction>2,491</ix:nonfraction>)</span></td><td></td></tr><tr><td><span>Other</span></td><td><span>(<ix:nonfraction>946</ix:nonfraction>)</span></td><td></td><td></td><td><span>(<ix:nonfraction>1,092</ix:nonfraction>)</span></td><td></td></tr><tr><td><span>Total deferred tax liabilities</span></td><td><span>(<ix:nonfraction>11,640</ix:nonfraction>)</span></td><td></td><td></td><td><span>(<ix:nonfraction>12,551</ix:nonfraction>)</span></td><td></td></tr><tr><td><span>Net deferred tax assets (liabilities)</span></td><td><span>$</span></td><td><span>(<ix:nonfraction>3,973</ix:nonfraction>)</span></td><td></td><td></td><td><span>$</span></td><td><span><ix:nonfraction>4,747</ix:nonfraction> </span></td><td></td></tr></table></ix:continuation></div><div><span>(1)</span><span>As required by the 2017 Tax Cuts and Jobs Act, effective January 1, 2022, our research and development expenditures were capitalized and amortized which resulted in substantially higher cash taxes for 2022 with an equal amount of deferred tax benefit.</span><span> </span></div><div><span>As of December 31, 2022, our federal, state, and foreign net operating loss carryforwards for income tax purposes were approximately $<ix:nonfraction>6.4</ix:nonfraction> billion, $<ix:nonfraction>14.6</ix:nonfraction> billion, and $<ix:nonfraction>1.8</ix:nonfraction> billion respectively. If not utilized, the federal net operating loss carryforwards will begin to expire in 2023, foreign net operating loss carryforwards will begin to expire in 2025 and the state net operating loss carryforwards will begin to expire in 2028. It is more likely than not that the majority of the net operating loss carryforwards will not be realized; therefore, we have recorded a valuation allowance against them. The net operating loss carryforwards are subject to various annual limitations under the tax laws of the different jurisdictions.</span></div><div><span>As of </span><span>December 31, 2022</span><span>, our Federal and California research and development credit carryforwards for income tax purposes were approximately $<ix:nonfraction>400</ix:nonfraction> million and $<ix:nonfraction>5.8</ix:nonfraction> billion, respectively. If not utilized, the Federal R&amp;D credit will begin to expire in 2037 and the California R&amp;D credit can be carried over indefinitely. We believe the majority of the federal tax credit and state tax credit is not likely to be realized.</span></div><div><span>As of </span><span>December 31, 2022</span><span>, our investment tax credit carryforwards for state income tax purposes were approximately $<ix:nonfraction>931</ix:nonfraction> million and will begin to expire in 2025. We use the flow-through method of accounting for investment tax credits. We believe this tax credit is not likely to be realized.</span></div><div><span>As of December 31, 2022, we maintained a valuation allowance with respect to California deferred tax assets, certain federal net operating losses, certain state net operating losses and tax credits, net deferred tax assets relating to certain Other Bets, and certain foreign net operating losses that we believe are not likely to be realized. We continue to reassess the remaining valuation allowance quarterly, and if future evidence allows for a partial or full release of the valuation allowance, a tax benefit will be recorded accordingly. </span></div></ix:continuation><div><div><div><span>81</span></div></div></div>